marijuana stocks news

UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of INSYS Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 – INSY

Click here to learn about the case: https://www.wongesq.com/pslra-sa/insys-therapeutics-inc?wire=1. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) INSYS had overstated its 2015 net revenue; (2) INSYS had misstated its sales allowances for 2016; (3) accordingly, the Company lacked effective internal controls over financial reporting; and (4) as a result, INSYS public statements were materially false and misleading at all relevant times.

If you suffered a loss in INSYS you have until May 16, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit https://www.wongesq.com/pslra-sa/insys-therapeutics-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EDXC Begins Mass Production on its CBD-Infused Gourmet Tea Beverages

Endexx Begins Mass Production on its CBD-Infused Gourmet Tea Beverages with The…

Curaleaf Holdings, Inc (CURLF) Secures EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device

Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification…

Falcon Technologies, Inc. (FLCN) Announces the Signing of an Exclusive 2 Year Worldwide License with Publicly-Traded Stevia Corp.

Falcon Technologies Announces the Signing of an Exclusive 2 Year Worldwide License…

CannTrust™ (CNTTF) reports record revenue for Q1 2018

CannTrust™ reports record revenue for Q1 2018 CannTrust Holdings Inc. (“CannTrust” or…